Serology for Trachoma Surveillance after Cessation of Mass Drug Administration: e0003555
Serology for Trachoma Surveillance after Cessation of Mass Drug Administration: e0003555
About this item
Full title
Author / Creator
Publisher
San Francisco: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
San Francisco: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Background Trachoma, caused by Chlamydia trachomatis (Ct), is the leading infectious cause of blindness worldwide. Yearly azithromycin mass drug administration (MDA) plays a central role in efforts to eliminate blinding trachoma as a public health problem. Programmatic decision-making is currently based on the prevalence of the clinical sign "trach...
Alternative Titles
Full title
Serology for Trachoma Surveillance after Cessation of Mass Drug Administration: e0003555
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1685625177
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1685625177
Other Identifiers
ISSN
1935-2727
E-ISSN
1935-2735
DOI
10.1371/journal.pntd.0003555
